Clinical Trial

Reducing Risk of Stroke and DementIa In patientS With COVert cERebrovascular Disease

Study acronym: DISCOVER
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of the DISCOVER study is to pilot acceptable approaches to people with covert cerebrovascular disease (CCD) and their follow-up. This is the first step in designing efficient randomised trials of treatments to reduce the risk of stroke or dementia in people with CCD.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2025-03-13; most recent amendment 2026-06-12.
Trial Details
NCT Number NCT06878430
Lead Sponsor University of Edinburgh
Collaborators: NHS Lothian
Conditions Covert Cerebrovascular Disease
Enrollment 100 participants
Start Date 2026-08
Primary Completion 2026-12 (estimated)
Study Completion 2027-06 (estimated)
Updated on ClinicalTrials.gov 2026-06-16